| Serial Number | 90322070 |
| Word Mark | LIBMUVO |
| Filing Date | Monday, November 16, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, September 16, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 15, 2021 |
| Goods and Services | pharmaceutical preparations and substances for the treatment of neurological conditions, disorders and diseases; pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, neurogenic symptoms, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, post-traumatic stress disorders, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's disease, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders, sleep and sleep disorders; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, neurogenic symptoms, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, post-traumatic stress disorders, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's disease, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders, sleep and sleep disorders; pure extracts of medicinal plants and herbs for medical purposes; dietetic foodstuffs for medicinal purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 15, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | GW Research Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Cambridge CB249BZ GB |
| Party Name | GW Research Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Cambridge CB249BZ GB |
| Event Date | Event Description |
| Thursday, November 19, 2020 | NEW APPLICATION ENTERED |
| Friday, January 15, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 26, 2021 | ASSIGNED TO EXAMINER |
| Monday, May 3, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, May 3, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Monday, May 3, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, May 3, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, May 12, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 26, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 15, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 15, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 10, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, September 15, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, September 15, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, September 15, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, September 15, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, February 1, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, February 1, 2022 | SOU EXTENSION 1 FILED |
| Tuesday, February 1, 2022 | SOU EXTENSION 1 GRANTED |
| Thursday, February 3, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 8, 2022 | SOU TEAS EXTENSION RECEIVED |
| Monday, August 8, 2022 | SOU EXTENSION 2 FILED |
| Monday, August 8, 2022 | SOU EXTENSION 2 GRANTED |
| Wednesday, August 10, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, February 10, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, February 10, 2023 | SOU EXTENSION 3 FILED |
| Friday, February 10, 2023 | SOU EXTENSION 3 GRANTED |
| Tuesday, February 14, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, July 12, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, July 12, 2023 | SOU EXTENSION 4 FILED |
| Wednesday, July 12, 2023 | SOU EXTENSION 4 GRANTED |
| Friday, July 14, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, January 18, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 18, 2024 | SOU EXTENSION 5 FILED |
| Monday, February 5, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, February 5, 2024 | SOU EXTENSION 5 GRANTED |
| Tuesday, February 6, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, September 16, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, September 16, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |